Chemclin Diagnostics Co., Ltd. (SHA:688468)
7.41
+0.17 (2.35%)
Apr 29, 2026, 3:00 PM CST
5.26% (1Y)
| Market Cap | 2.86B |
| Revenue (ttm) | 332.68M |
| Net Income (ttm) | 43.91M |
| Shares Out | 394.59M |
| EPS (ttm) | 0.11 |
| PE Ratio | 65.82 |
| Forward PE | n/a |
| Dividend | 0.13 (1.71%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 5,404,820 |
| Average Volume | 2,907,887 |
| Open | 7.20 |
| Previous Close | 7.24 |
| Day's Range | 7.18 - 7.49 |
| 52-Week Range | 6.76 - 9.12 |
| Beta | 0.13 |
| RSI | 46.99 |
| Earnings Date | Apr 29, 2026 |